Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mehta

Showing results (1051-1060 of 1,216) with videos related to

Pageof 122
Sort By:
Clinical and Translational Radiation Oncology|December 5, 2022
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatmentsMichael D Chuong, Mary Ann Clark, Lauren E Henke, et al.
Neuro-Oncology|May 21, 2024
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncologyRifaquat Rahman, Diana D Shi, Zachary J Reitman, et al.
Annals of Clinical and Translational Neurology|September 15, 2021
Deep clinicopathological phenotyping identifies a previously unrecognized pathogenic EMD splice variantDaniel G Calame, Jawid M Fatih, Isabella Herman, et al.
Neuro-Oncology|February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent GlioblastomaChristina I Tsien, Stephanie L Pugh, Adam P Dicker, et al.
Bjpsych Open|August 10, 2022
Efficacy and moderators of cognitive therapy versus behavioural activation for adults with depression: study protocol of a systematic review and meta-analysis of individual participant dataEllen Driessen, Zachary D Cohen, Lorenzo Lorenzo-Luaces, et al.
Journal of Neuro-Oncology|April 22, 2025
Integrating a novel tablet-based digital neurocognitive assessment tool in brain metastases patientsEyub Y Akdemir, Selin Gurdikyan, Thailin Companioni Reyes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2017
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancerSteven H Lin, Kenneth W Merrell, Jincheng Shen, et al.
Neuro-Oncology Practice|December 14, 2019
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525H Ian Robins, Jens Eickhoff, Mark R Gilbert, et al.
Neuro-Oncology|October 7, 2025
Radiation therapy (RT) alone versus RT plus radiofrequency ablation/vertebral augmentation for painful spine metastasis: a phase 2 randomized controlled trialRupesh Kotecha, Omer Gal, Haley Appel, et al.
Pageof 122

Showing results (1051-1060 of 1,216) with videos related to

Sort By:
Pageof 122
Clinical and Translational Radiation Oncology|December 5, 2022
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatmentsMichael D Chuong, Mary Ann Clark, Lauren E Henke, et al.
Neuro-Oncology|May 21, 2024
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncologyRifaquat Rahman, Diana D Shi, Zachary J Reitman, et al.
Annals of Clinical and Translational Neurology|September 15, 2021
Deep clinicopathological phenotyping identifies a previously unrecognized pathogenic EMD splice variantDaniel G Calame, Jawid M Fatih, Isabella Herman, et al.
Neuro-Oncology|February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent GlioblastomaChristina I Tsien, Stephanie L Pugh, Adam P Dicker, et al.
Bjpsych Open|August 10, 2022
Efficacy and moderators of cognitive therapy versus behavioural activation for adults with depression: study protocol of a systematic review and meta-analysis of individual participant dataEllen Driessen, Zachary D Cohen, Lorenzo Lorenzo-Luaces, et al.
Journal of Neuro-Oncology|April 22, 2025
Integrating a novel tablet-based digital neurocognitive assessment tool in brain metastases patientsEyub Y Akdemir, Selin Gurdikyan, Thailin Companioni Reyes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2017
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancerSteven H Lin, Kenneth W Merrell, Jincheng Shen, et al.
Neuro-Oncology Practice|December 14, 2019
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525H Ian Robins, Jens Eickhoff, Mark R Gilbert, et al.
Neuro-Oncology|October 7, 2025
Radiation therapy (RT) alone versus RT plus radiofrequency ablation/vertebral augmentation for painful spine metastasis: a phase 2 randomized controlled trialRupesh Kotecha, Omer Gal, Haley Appel, et al.
Pageof 122